Literature DB >> 7812941

A precise, rapid and sensitive in vitro assay to measure the adhesion of ovarian tumour cells to peritoneal mesothelial cells.

J B Catterall1, M J Gardner, L M Jones, G A Thompson, G A Turner.   

Abstract

Ovarian cancer is the second most common gynaecological cancer in the UK, causing 2000 deaths per year. It spreads by shedding cells which attach to the mesothelial lining of the peritoneal cavity. In order to quantitatively study this interaction, a model system was developed in which mesothelial cells were cultured as monolayers in multiwell plates, and ovarian tumour cells were added that had been pre-labelled with a fluorescent dye (calcein). Synchronous interaction between the two populations was achieved by brief centrifugation at low g and the degree of attachment was measured on an automated fluorimeter after washing away the unbound cells. Using this procedure it was possible to measure tumour cell adhesion in 96 wells in 3-4 h. The reproducibility of the method was high even after short incubation times and the background absorbance was so low that the adhesion of less than a 1000 cells could be easily detected. The method works equally well for all ovarian tumour cell lines so far studied, and in preliminary experiments, it was shown that it can be used to screen for the effects of various blocking agents.

Entities:  

Mesh:

Year:  1994        PMID: 7812941     DOI: 10.1016/0304-3835(94)90223-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Binding of ovarian cancer cells to immobilized hyaluronic acid.

Authors:  J B Catterall; M J Gardner; L M Jones; G A Turner
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

Review 2.  CD44 in inflammation and metastasis.

Authors:  J Lesley; R Hyman; N English; J B Catterall; G A Turner
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

3.  Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis.

Authors:  M J Gardner; J B Catterall; L M Jones; G A Turner
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

4.  Binding of ovarian cancer cells to immobilized hyaluronic acid.

Authors:  J B Catterall; M J Gardner; L M Jones; G A Turner
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

5.  Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan.

Authors:  J B Catterall; L M Jones; G A Turner
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

6.  CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells.

Authors:  K Lessan; D J Aguiar; T Oegema; L Siebenson; A P Skubitz
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

7.  Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion.

Authors:  L M Jones; M J Gardner; J B Catterall; G A Turner
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

8.  Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers.

Authors:  W M U van Grevenstein; L J Hofland; M E E van Rossen; P M van Koetsveld; J Jeekel; C H J van Eijck
Journal:  Dig Dis Sci       Date:  2007-03-30       Impact factor: 3.199

9.  Production of IL1-beta by ovarian cancer cells induces mesothelial cell beta1-integrin expression facilitating peritoneal dissemination.

Authors:  Takafumi Watanabe; Toshihiro Hashimoto; Takashi Sugino; Shu Soeda; Hiroshi Nishiyama; Yutaka Morimura; Hidekazu Yamada; Steve Goodison; Keiya Fujimori
Journal:  J Ovarian Res       Date:  2012-02-01       Impact factor: 4.234

10.  The role of superoxide anions in the development of distant tumour recurrence.

Authors:  M ten Kate; J B C van der Wal; W Sluiter; L J Hofland; J Jeekel; P Sonneveld; C H J van Eijck
Journal:  Br J Cancer       Date:  2006-11-07       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.